The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC).
 
Eve Maubec
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Sabine Helfen
No Relationships to Disclose
 
Isabelle Scheer-Senyarich
No Relationships to Disclose
 
Marouane Boubaya
No Relationships to Disclose
 
Olivier Schischmanoff
No Relationships to Disclose
 
Céline Alloux
No Relationships to Disclose
 
Lydia Deschamps
No Relationships to Disclose
 
Peter Petrow
Stock and Other Ownership Interests - ACRIM - private radiology clinic; Polyclinique St Côme
Travel, Accommodations, Expenses - GE Healthcare; Guerbet
 
Isabelle Lopez
Stock and Other Ownership Interests - ACRIM - private radiology clinic; Polyclinique St Côme
Travel, Accommodations, Expenses - GE Healthcare; Guerbet
 
Annick Tibi
No Relationships to Disclose
 
Vincent Levy
No Relationships to Disclose